Lele Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lele Wu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Hyeong-Cheol Yang
Department of Dental Biomaterials Science, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
3 shared publications - Sang Hoon Choi
Department of Dental Biomaterials Science, Dental Research Institute, School of Dentistry, Seoul National University, 101, Deahak-ro, Jongno-gu, Seoul 03080, South Korea
3 shared publications - Gyeung Mi Seon
Department of Dental Biomaterials Science, Dental Research Institute, School of Dentistry, Seoul National University, 101, Deahak-ro, Jongno-gu, Seoul 03080, South Korea
2 shared publications - Yongjoon Kim
Bone Science Evaluation Team, Tissue Regeneration Institute, Osstem Implant Co. Ltd., Seoul, Republic of Korea
2 shared publications Bum-Soon Lim
Department of Dental Biomaterials Science, Dental Research Institute, School of Dentistry, Seoul National University, 101, Deahak-ro, Jongno-gu, Seoul, 03080, South Korea
1 shared publicationChunning Gu
Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology Nanjing University Nanjing China
1 shared publication
Latest Publications
- Open Access
- 30 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (40) , e71648
Targeting CD300a Signaling With a Phosphatidylserine‐Presenting Hydrogel Rescues Macrophage Dysfunction and Accelerates Diabetic Wound Healing
The delayed healing of diabetic wounds involves both impaired efferocytosis and dysfunctional phosphatidylserine (PS) receptor signaling, leading to macrophage defects in migration, persistent M1 polarization, and diminished cellular resilience. To address this multifaceted pathology, a bioactive wound dressing was developed by incorporating PEGylated RGD‐grafted phosphatidylserine liposomes (PEG/RGD‐PSLs) into a photocrosslinkable hyaluronic acid methacryloyl (HAMA) hydrogel matrix. This platform provides sustained, delivery of a biomimetic “eat‐me” signal while actively reprogramming macrophage behavior. Under diabetic‐mimicking stress conditions, PEG/RGD‐PSLs significantly enhanced macrophage migration, promoted M1‐to‐M2 phenotypic transition, and conferred robust cytoprotection by preserving mitochondrial integrity, attenuating oxidative stress, and suppressing pathological extracellular vesicle release. Mechanistically, PS binding upregulated the inhibitory receptor CD300a, which suppressed the MyD88/NF‐κB pathway and downregulated pro‐inflammatory genes. Critically, siRNA‐mediated CD300a knockdown abolished these anti‐inflammatory and NF‐κB‐suppressive effects, establishing CD300a as necessary for therapeutic action. In a diabetic rat model, a single application of the bioactive hydrogel significantly accelerated wound closure, stimulated angiogenesis, improved organized collagen deposition, and actively shifted the wound immune microenvironment toward a pro‐reparative M2‐dominant state. Collectively, this study identifies the PS/CD300a/NF‐κB axis as a key regulatory node for rescuing macrophage dysfunction and establishes a functionally active hydrogel‐based therapy for chronic diabetic wounds.
- 30 August 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (40) , e71648
Open AccessTargeting CD300a Signaling With a Phosphatidylserine‐Presenting Hydrogel Rescues Macrophage Dysfunction and Accelerates Diabetic Wound Healing
The delayed healing of diabetic wounds involves both impaired efferocytosis and dysfunctional phosphatidylserine (PS) receptor signaling, leading to macrophage defects in migration, persistent M1 polarization, and diminished cellular resilience. To address this multifaceted pathology, a bioactive wound dressing was developed by incorporating PEGylated RGD‐grafted phosphatidylserine liposomes (PEG/RGD‐PSLs) into a photocrosslinkable hyaluronic acid methacryloyl (HAMA) hydrogel matrix. This platform provides sustained, delivery of a biomimetic “eat‐me” signal while actively reprogramming macrophage behavior. Under diabetic‐mimicking stress conditions, PEG/RGD‐PSLs significantly enhanced macrophage migration, promoted M1‐to‐M2 phenotypic transition, and conferred robust cytoprotection by preserving mitochondrial integrity, attenuating oxidative stress, and suppressing pathological extracellular vesicle release. Mechanistically, PS binding upregulated the inhibitory receptor CD300a, which suppressed the MyD88/NF‐κB pathway and downregulated pro‐inflammatory genes. Critically, siRNA‐mediated CD300a knockdown abolished these anti‐inflammatory and NF‐κB‐suppressive effects, establishing CD300a as necessary for therapeutic action. In a diabetic rat model, a single application of the bioactive hydrogel significantly accelerated wound closure, stimulated angiogenesis, improved organized collagen deposition, and actively shifted the wound immune microenvironment toward a pro‐reparative M2‐dominant state. Collectively, this study identifies the PS/CD300a/NF‐κB axis as a key regulatory node for rescuing macrophage dysfunction and establishes a functionally active hydrogel‐based therapy for chronic diabetic wounds.
- 22 December 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1358-1372
Synergistic effects of arginine–glycine–aspartic acid and phosphatidylserine on the surface immunomodulation and osseointegration of titanium implants
The control of macrophage polarization is important in bone tissue regeneration such as osseointegration. In this study, a coating method was developed to improve the osseointegration of titanium (Ti) implants by generating an immunomodulatory effect. The surface of the Ti discs was coated with a poly(lactide-co-glycolide)(PLGA) polymer, phosphatidylserine (PS), and arginine–glycine–aspartic acid (RGD) peptide conjugated phospholipid. In in vitro assay using mouse bone marrow-derived macrophages (BMDMs), the most significant expression of the M2 marker genes (Arg-1, YM-1, FIZZ1) and CD206, an M2 surface marker, was obtained with coatings containing 6 mol% RGD conjugates and phospholipids consisting of 50 mol% PS. The M2-inducing effect of RGD and PS was also verified in rat femurs where coated Ti rods were implanted. The RGD and PS coating significantly enhanced the osseointegration of the Ti implants. Moreover, a biomechanical push-out test showed that the RGD and PS coating increased the interfacial binding force between the bone and implants. These results indicate that PS and RGD can be applied to the solid surface of implantable biomedical devices to improve immunomodulation and tissue regeneration.
- 22 December 2022
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 11 (4) , 1358-1372
Synergistic effects of arginine–glycine–aspartic acid and phosphatidylserine on the surface immunomodulation and osseointegration of titanium implants
The control of macrophage polarization is important in bone tissue regeneration such as osseointegration. In this study, a coating method was developed to improve the osseointegration of titanium (Ti) implants by generating an immunomodulatory effect. The surface of the Ti discs was coated with a poly(lactide-co-glycolide)(PLGA) polymer, phosphatidylserine (PS), and arginine–glycine–aspartic acid (RGD) peptide conjugated phospholipid. In in vitro assay using mouse bone marrow-derived macrophages (BMDMs), the most significant expression of the M2 marker genes (Arg-1, YM-1, FIZZ1) and CD206, an M2 surface marker, was obtained with coatings containing 6 mol% RGD conjugates and phospholipids consisting of 50 mol% PS. The M2-inducing effect of RGD and PS was also verified in rat femurs where coated Ti rods were implanted. The RGD and PS coating significantly enhanced the osseointegration of the Ti implants. Moreover, a biomechanical push-out test showed that the RGD and PS coating increased the interfacial binding force between the bone and implants. These results indicate that PS and RGD can be applied to the solid surface of implantable biomedical devices to improve immunomodulation and tissue regeneration.
- 1 December 2021
- Published by Elsevier in Biomaterials
- Vol. 279, 121239
Effects of RGD-grafted phosphatidylserine-containing liposomes on the polarization of macrophages and bone tissue regeneration
- 1 December 2021
- Published by Elsevier in Biomaterials
- Vol. 279, 121239
Effects of RGD-grafted phosphatidylserine-containing liposomes on the polarization of macrophages and bone tissue regeneration
- 30 June 2021
- Published by Korean Society for Dental Materials in Korean Journal of Dental Materials
- Vol. 48 (2) , 125-134
Evaluation of cytotoxicity and inflammatory tissue response of mineral trioxide aggregates containing dicalcium phosphate dihydrate
본 연구에서는 Mineral Trioxide Aggregate(MTA)의 생체적합성에 대한 dicalcium phosphate dihydrate (DCPD)의 영향을 평가하고자 하였다. MTA 경화 시 발생하는 pH 상승을 억제하고자 DCPD를 OrthoMTA에 첨가하여 세포독성과 피하염증반응의 변화를 관찰하였다. 인산완충생리식염수에 침지한 OrthoMTA와 DCPD-OrthoMTA의 pH를 측정한 결과, OrthoMTA와 DCPD-OrthoMTA는 측정 1일째에 각각 12.5와 12.0의 pH를 보였다. 마지막 측정시점인 19일에 OrthoMTA는 평균 11.6을 보인 반면, DCPD-OrthoMTA는 8.8을 나타내었다. NIH 3T3 섬유아세포에 대한 세포독성은 높은 농도의 용출액(50% 이상)에서 DCPD가 OrthoMTA의 세포독성을 억제하는 효과를 보였다(p 0.05). 마우스 피하이식 시험에서는 ProRoot MTA, OrthoMTA, DCPD-OrthoMTA 간의 염증반응의 차이는 발생하지 않았다. 따라서 DCPD의 MTA 세포독성을 낮추는 효과와 본 실험 조건에서의 피하염증발생에 대한 영향은 서로 유의한 상관관계를 보이지 않는 것으로 사료된다.
- 30 June 2021
- Published by Korean Society for Dental Materials in Korean Journal of Dental Materials
- Vol. 48 (2) , 125-134
Evaluation of cytotoxicity and inflammatory tissue response of mineral trioxide aggregates containing dicalcium phosphate dihydrate
본 연구에서는 Mineral Trioxide Aggregate(MTA)의 생체적합성에 대한 dicalcium phosphate dihydrate (DCPD)의 영향을 평가하고자 하였다. MTA 경화 시 발생하는 pH 상승을 억제하고자 DCPD를 OrthoMTA에 첨가하여 세포독성과 피하염증반응의 변화를 관찰하였다. 인산완충생리식염수에 침지한 OrthoMTA와 DCPD-OrthoMTA의 pH를 측정한 결과, OrthoMTA와 DCPD-OrthoMTA는 측정 1일째에 각각 12.5와 12.0의 pH를 보였다. 마지막 측정시점인 19일에 OrthoMTA는 평균 11.6을 보인 반면, DCPD-OrthoMTA는 8.8을 나타내었다. NIH 3T3 섬유아세포에 대한 세포독성은 높은 농도의 용출액(50% 이상)에서 DCPD가 OrthoMTA의 세포독성을 억제하는 효과를 보였다(p 0.05). 마우스 피하이식 시험에서는 ProRoot MTA, OrthoMTA, DCPD-OrthoMTA 간의 염증반응의 차이는 발생하지 않았다. 따라서 DCPD의 MTA 세포독성을 낮추는 효과와 본 실험 조건에서의 피하염증발생에 대한 영향은 서로 유의한 상관관계를 보이지 않는 것으로 사료된다.